Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBVNYSE:IBMNYSE:O On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$189.50-0.7%$187.37$163.63▼$218.66$334.34B0.486.25 million shs3.71 million shsIBMInternational Business Machines$291.66+1.4%$268.36$173.95▼$296.16$271.36B0.694.22 million shs1.85 million shsORealty Income$57.70-0.1%$56.75$50.71▼$64.88$52.09B0.755.24 million shs2.94 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie0.00%+4.19%+1.17%+1.57%+15.66%IBMInternational Business Machines0.00%+0.68%+9.92%+28.30%+65.99%ORealty Income0.00%+1.11%+3.05%+4.69%+10.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABBVAbbVie4.9079 of 5 stars3.45.03.33.92.81.71.3IBMInternational Business Machines4.4275 of 5 stars2.33.03.33.54.10.81.3ORealty Income3.876 of 5 stars2.24.02.51.72.91.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.81Moderate Buy$211.2911.50% UpsideIBMInternational Business Machines 2.50Moderate Buy$257.50-11.71% DownsideORealty Income 2.31Hold$61.156.00% UpsideCurrent Analyst Ratings BreakdownLatest ABBV, IBM, and O Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/2/2025IBMInternational Business MachinesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$270.00 ➝ $310.006/20/2025IBMInternational Business MachinesWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $325.006/18/2025IBMInternational Business MachinesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $320.006/11/2025ABBVAbbVieCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold$205.006/9/2025ABBVAbbVieBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold$204.006/9/2025IBMInternational Business MachinesBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$270.00 ➝ $290.005/15/2025IBMInternational Business MachinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$276.00 ➝ $285.005/14/2025ABBVAbbVieCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$210.00 ➝ $205.005/13/2025ORealty IncomeUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$64.00 ➝ $62.005/12/2025ORealty IncomeScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$57.00 ➝ $58.005/10/2025IBMInternational Business MachinesCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$56.33B5.94$14.94 per share12.68$1.90 per share99.74IBMInternational Business Machines$62.75B4.32$15.51 per share18.81$29.62 per share9.85ORealty Income$5.27B9.88$3.81 per share15.14$44.62 per share1.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.28B$2.3580.6413.561.267.31%412.03%13.11%7/31/2025 (Estimated)IBMInternational Business Machines$6.02B$5.8150.2025.146.138.71%37.43%7.00%7/23/2025 (Estimated)ORealty Income$860.77M$1.1052.4513.364.0418.15%2.51%1.42%8/4/2025 (Estimated)Latest ABBV, IBM, and O EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/24/2025Q2 2025ABBVAbbVie$3.24N/AN/AN/A$14.93 billionN/A7/23/2025Q2 2025IBMInternational Business Machines$2.64N/AN/AN/A$16.58 billionN/A5/5/2025Q1 2025ORealty Income$1.06$1.06N/A$1.06$1.28 billion$1.31 billion4/25/2025Q1 2025ABBVAbbVie$2.40$2.46+$0.06$0.72$12.91 billion$13.34 billion4/23/2025Q1 2025IBMInternational Business Machines$1.42$1.60+$0.18$1.11$14.41 billion$14.54 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.563.46%N/A279.15%53 YearsIBMInternational Business Machines$6.722.30%N/A115.66%30 YearsORealty Income$3.235.60%N/A293.64%1 YearsLatest ABBV, IBM, and O DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/20/2025ABBVAbbViequarterly$1.643.54%7/15/20257/15/20258/15/20256/10/2025ORealty Incomejul 25$0.26905.6%7/1/20257/1/20257/15/20255/12/2025ORealty Incomejun 25$0.26855.8%6/2/20256/2/20256/13/20254/29/2025IBMInternational Business Machinesquarterly$1.682.82%5/9/20256/10/20254/8/2025ORealty Incomemay 25$0.26856%5/1/20255/1/20255/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVie44.140.760.64IBMInternational Business Machines2.091.010.97ORealty Income0.691.741.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%IBMInternational Business Machines58.96%ORealty Income70.81%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.25%IBMInternational Business Machines0.18%ORealty Income0.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie55,0001.77 billion1.76 billionOptionableIBMInternational Business Machines293,400929.40 million927.72 millionOptionableORealty Income400903.08 million902.18 millionOptionableABBV, IBM, and O HeadlinesRecent News About These CompaniesMarketBeat Week in Review – 06/30 - 07/04...4 hours ago | marketbeat.comBrookstone Capital Management Purchases 12,853 Shares of Realty Income Corporation (NYSE:O)4 hours ago | marketbeat.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever5 hours ago | fool.comPrincipal Financial Group Inc. Reduces Stock Holdings in Realty Income Corporation (NYSE:O)5 hours ago | marketbeat.comRealty Income Corporation (NYSE:O) Shares Bought by IFM Investors Pty LtdJuly 4 at 8:03 AM | marketbeat.comD.A. Davidson & CO. Increases Stock Holdings in Realty Income Corporation (NYSE:O)July 4 at 5:56 AM | marketbeat.comPinnacle Financial Partners Inc Has $264,000 Stock Position in Realty Income Corporation (NYSE:O)July 4 at 5:17 AM | marketbeat.comNeed Income? Europe's Commercial Real Estate Debt Is Worth A LookJuly 3 at 10:54 PM | seekingalpha.comBig Yields, Big Companies, Big Investment OpportunitiesJuly 3 at 8:05 PM | fool.comWill Realty Income Cut Its Dividend?July 3 at 8:17 AM | seekingalpha.comIf I Could Buy Only 1 High-Yield Dividend Stock for Passive Income in July, This Would Be ItJuly 3 at 7:01 AM | fool.comDAVENPORT & Co LLC Grows Holdings in Realty Income Corporation (NYSE:O)July 3 at 5:18 AM | marketbeat.comInvestors Heavily Search Realty Income Corporation (O): Here is What You Need to KnowJuly 2 at 10:00 AM | zacks.comWhy Realty Income’s 5.59% Yield Makes It a Must-Buy REIT...July 2 at 7:30 AM | marketbeat.comKBC Group NV Has $9.31 Million Holdings in Realty Income Corporation (NYSE:O)July 2 at 4:54 AM | marketbeat.comJim Cramer's Safest Income Stock TodayJuly 1, 2025 | 247wallst.comRealty Income (NYSE:O) Trading 1.2% Higher - Here's WhyJuly 1, 2025 | marketbeat.comCan Realty Income's Expansion Into New Sectors Fuel Future Growth?July 1, 2025 | zacks.comSumitomo Mitsui DS Asset Management Company Ltd Purchases 12,699 Shares of Realty Income Corporation (NYSE:O)July 1, 2025 | marketbeat.comBLB&B Advisors LLC Has $7.86 Million Holdings in Realty Income Corporation (NYSE:O)July 1, 2025 | marketbeat.comNew York State Teachers Retirement System Sells 6,743 Shares of Realty Income Corporation (NYSE:O)July 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesDon’t Miss These 2 Small Quantum Stocks Poised to PopBy Gabriel Osorio-Mazilli | June 24, 2025View Don’t Miss These 2 Small Quantum Stocks Poised to Pop3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?New Catalysts to Drive NVIDIA’s Stock Price Even HigherBy Thomas Hughes | June 16, 2025View New Catalysts to Drive NVIDIA’s Stock Price Even HigherTop 3 Bank Stocks to Watch as Fed Rate Cuts LoomBy Chris Markoch | June 25, 2025View Top 3 Bank Stocks to Watch as Fed Rate Cuts LoomDollar Down 10%? These 3 Stocks Could SoarBy Chris Markoch | July 1, 2025View Dollar Down 10%? These 3 Stocks Could SoarABBV, IBM, and O Company DescriptionsAbbVie NYSE:ABBV$189.50 -1.25 (-0.66%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$188.90 -0.60 (-0.32%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.International Business Machines NYSE:IBM$291.65 +4.01 (+1.39%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$291.73 +0.08 (+0.03%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Realty Income NYSE:O$57.70 -0.06 (-0.10%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$57.70 +0.01 (+0.01%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O). More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
